ArticleDrug design, development and therapy2020

S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway.

Guang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.